ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Nephrology

Top Nephrology Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WILLIAM GRUBB MD

Nephrology

19,195

$1.51M

700
585 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$78
Average prescription price

Avg: $106

VALERIE JONES-FREEMAN MD

Nephrology

15,133

$726K

407
303 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

31%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $106

RAUL SANTOS M.D.

Nephrology

13,836

$1.24M

588
347 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$89
Average prescription price

Avg: $106

CARLOS MARTINEZ M.D.

Nephrology

12,611

$1.27M

623
412 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$101
Average prescription price

Avg: $106

ROBERT SHAY MD

Nephrology

12,430

$742K

695
491 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $106

AHMED ELSHARKAWI M.D.

Nephrology

11,756

$669K

504
330 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $106

ZHIQIANG ZHANG MD

Nephrology

11,669

$1.58M

525
362 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$135
Average prescription price

Avg: $106

BABATUNDE FARIYIKE MD

Nephrology

10,800

$1.34M

355
218 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$124
Average prescription price

Avg: $106

WATERS HICKS M.D.

Nephrology

10,313

$1.02M

564
331 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$99
Average prescription price

Avg: $106

COLETTE LEE-LEWIS MD

Nephrology

10,197

$923K

496
299 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$91
Average prescription price

Avg: $106

EDWARD HIMOT M.D.

Nephrology

9,430

$704K

632
501 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$75
Average prescription price

Avg: $106

BRANDI WYNNE MD

Nephrology

9,128

$426K

291
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $106

MARK WOOD MD

Nephrology

8,865

$854K

234
127 are 65+

14%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$96
Average prescription price

Avg: $106

MANOJ PATEL M.D.

Nephrology

8,594

$581K

400
269 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$68
Average prescription price

Avg: $106

PADMANABH MARAMREDDY M.D.

Nephrology

8,274

$581K

340
254 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$70
Average prescription price

Avg: $106

DINESH BHATIA MD

Nephrology

8,024

$1.35M

492
404 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$168
Average prescription price

Avg: $106

MARIA ORIG MD

Nephrology

7,706

$768K

577
404 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$100
Average prescription price

Avg: $106

MUFID OTHMAN M.D.

Nephrology

7,699

$839K

328
187 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$109
Average prescription price

Avg: $106

JAMES JACKSON MD

Nephrology

7,647

$799K

552
387 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 26%

$105
Average prescription price

Avg: $106

LEO OVADJE M.D.

Nephrology

7,540

$543K

435
262 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$72
Average prescription price

Avg: $106

EMAD AHMED MD

Nephrology

7,207

$737K

421
258 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$102
Average prescription price

Avg: $106

ARUNAS URBONAS M.D.

Nephrology

7,173

$602K

636
409 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$84
Average prescription price

Avg: $106

MURALIDHARAN JAGADEESAN MD

Nephrology

6,960

$501K

332
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$72
Average prescription price

Avg: $106

DWIGHT MCLEISH M.D.

Nephrology

6,663

$502K

194
109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$75
Average prescription price

Avg: $106

SHAZIA KHAN MD

Nephrology

6,621

$663K

579
431 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$100
Average prescription price

Avg: $106

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank